Cochrane Abstracts
Nebulised morphine for severe interstitial lung disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Nebulised Morphine for Severe Interstitial Lung Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438418/all/Nebulised_morphine_for_severe_interstitial_lung_disease.
Nebulised morphine for severe interstitial lung disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438418/all/Nebulised_morphine_for_severe_interstitial_lung_disease. Accessed April 30, 2025.
Nebulised morphine for severe interstitial lung disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438418/all/Nebulised_morphine_for_severe_interstitial_lung_disease
Nebulised Morphine for Severe Interstitial Lung Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438418/all/Nebulised_morphine_for_severe_interstitial_lung_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nebulised morphine for severe interstitial lung disease
ID - 438418
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438418/all/Nebulised_morphine_for_severe_interstitial_lung_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
